Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 25% ± 7% | |
epithelial cell | 5 studies | 25% ± 6% | |
GABAergic neuron | 3 studies | 38% ± 7% | |
glutamatergic neuron | 3 studies | 45% ± 4% | |
macrophage | 3 studies | 17% ± 3% | |
astrocyte | 3 studies | 26% ± 9% | |
oligodendrocyte | 3 studies | 21% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 4722.98 | 459 / 459 | 100% | 46.76 | 1118 / 1118 |
esophagus | 100% | 4450.28 | 1445 / 1445 | 100% | 40.84 | 183 / 183 |
ovary | 100% | 5499.54 | 180 / 180 | 100% | 25.78 | 430 / 430 |
prostate | 100% | 4599.19 | 245 / 245 | 100% | 37.01 | 502 / 502 |
uterus | 100% | 5359.12 | 170 / 170 | 100% | 33.80 | 459 / 459 |
lung | 100% | 3811.52 | 578 / 578 | 100% | 34.18 | 1154 / 1155 |
brain | 100% | 3446.72 | 2637 / 2642 | 100% | 39.19 | 705 / 705 |
thymus | 100% | 4113.37 | 653 / 653 | 100% | 30.50 | 603 / 605 |
adrenal gland | 100% | 4900.51 | 258 / 258 | 99% | 31.60 | 228 / 230 |
intestine | 100% | 4312.75 | 966 / 966 | 99% | 29.59 | 522 / 527 |
liver | 100% | 1828.03 | 226 / 226 | 99% | 21.20 | 402 / 406 |
kidney | 100% | 2898.83 | 89 / 89 | 99% | 33.02 | 892 / 901 |
stomach | 100% | 3117.33 | 359 / 359 | 99% | 31.18 | 283 / 286 |
pancreas | 99% | 2352.25 | 326 / 328 | 99% | 28.33 | 177 / 178 |
bladder | 100% | 4482.81 | 21 / 21 | 99% | 28.61 | 498 / 504 |
skin | 100% | 7711.71 | 1809 / 1809 | 96% | 36.72 | 452 / 472 |
blood vessel | 100% | 6194.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.24 | 29 / 29 |
spleen | 100% | 4228.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.79 | 1 / 1 |
adipose | 100% | 4550.20 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 2275.03 | 835 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 21.63 | 77 / 80 |
muscle | 95% | 1344.94 | 765 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 3246.20 | 854 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0042254 | Biological process | ribosome biogenesis |
GO_0034644 | Biological process | cellular response to UV |
GO_0010498 | Biological process | proteasomal protein catabolic process |
GO_0031175 | Biological process | neuron projection development |
GO_0070914 | Biological process | UV-damage excision repair |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0048708 | Biological process | astrocyte differentiation |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0010467 | Biological process | gene expression |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0031464 | Cellular component | Cul4A-RING E3 ubiquitin ligase complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0080008 | Cellular component | Cul4-RING E3 ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0031465 | Cellular component | Cul4B-RING E3 ubiquitin ligase complex |
GO_0005634 | Cellular component | nucleus |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | CUL4B |
Protein name | Cullin-4B (CUL-4B) Cullin 4B |
Synonyms | hCG_40765 KIAA0695 |
Description | FUNCTION: Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins . The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition subunit . CUL4B may act within the complex as a scaffold protein, contributing to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme . Plays a role as part of the E3 ubiquitin-protein ligase complex in polyubiquitination of CDT1, histone H2A, histone H3 and histone H4 in response to radiation-induced DNA damage . Targeted to UV damaged chromatin by DDB2 and may be important for DNA repair and DNA replication . A number of DCX complexes (containing either TRPC4AP or DCAF12 as substrate-recognition component) are part of the DesCEND (destruction via C-end degrons) pathway, which recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation . The DCX(AMBRA1) complex is a master regulator of the transition from G1 to S cell phase by mediating ubiquitination of phosphorylated cyclin-D (CCND1, CCND2 and CCND3) . The DCX(AMBRA1) complex also acts as a regulator of Cul5-RING (CRL5) E3 ubiquitin-protein ligase complexes by mediating ubiquitination and degradation of Elongin-C (ELOC) component of CRL5 complexes . Required for ubiquitination of cyclin E (CCNE1 or CCNE2), and consequently, normal G1 cell cycle progression . Regulates the mammalian target-of-rapamycin (mTOR) pathway involved in control of cell growth, size and metabolism . Specific CUL4B regulation of the mTORC1-mediated pathway is dependent upon 26S proteasome function and requires interaction between CUL4B and MLST8 . With CUL4A, contributes to ribosome biogenesis . . |
Accessions | ENST00000681090.1 A0A7P0T809 ENST00000679844.1 A0A7P0T9C8 A0A7P0T9L3 A0A669KAU9 A0A7P0T8P8 ENST00000674137.11 K4DI93 A0A7P0T9D0 ENST00000673919.1 ENST00000371323.3 [Q13620-3] A0A7P0T9R8 A0A7P0Z4E4 A0A669KBG9 A0A804CL36 ENST00000679432.1 A0A7P0T9P5 ENST00000681908.1 A0A7P0TAF9 ENST00000680988.1 A0A7P0Z439 ENST00000681253.1 [Q13620-2] A0A7P0T894 ENST00000681652.1 [Q13620-2] ENST00000404115.8 ENST00000680918.1 ENST00000680673.1 [Q13620-2] ENST00000486604.1 ENST00000674073.2 A0A669KAX4 ENST00000681333.1 ENST00000679927.1 ENST00000681189.1 A0A7P0T954 ENST00000681869.1 ENST00000371322.11 [Q13620-1] ENST00000681206.1 ENST00000681080.1 ENST00000680474.1 A0A7P0TAQ3 ENST00000679405.1 Q13620 ENST00000336592.11 A0A7P0T8W4 A0A7P0Z4G9 |